128 related articles for article (PubMed ID: 32908968)
1. Neoadjuvant therapy strategies for advanced gastric cancer: Current innovations and future challenges.
Zhu Z; Gong YB; Xu HM
Chronic Dis Transl Med; 2020 Sep; 6(3):147-157. PubMed ID: 32908968
[TBL] [Abstract][Full Text] [Related]
2. Current status of neoadjuvant immunotherapy for the treatment of gastric cancer.
Zhang X; Liu B; Wang R; Li X; Zhou W
Clin Transl Oncol; 2024 Mar; ():. PubMed ID: 38504071
[TBL] [Abstract][Full Text] [Related]
3. Present status and perspective of chemotherapy for patients with unresectable advanced or metastatic gastric cancer in Japan.
Yamada Y
Glob Health Med; 2020 Jun; 2(3):156-163. PubMed ID: 33330800
[TBL] [Abstract][Full Text] [Related]
4. [Neoadjuvant treatment for locally advanced gastric cancer].
Zhao LL; Zhao DB; Chen YT
Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):907-911. PubMed ID: 33256300
[TBL] [Abstract][Full Text] [Related]
5. Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial.
Iwasaki Y; Terashima M; Mizusawa J; Katayama H; Nakamura K; Katai H; Yoshikawa T; Ito S; Kaji M; Kimura Y; Hirao M; Yamada M; Kurita A; Takagi M; Lee SW; Takagane A; Yabusaki H; Hihara J; Boku N; Sano T; Sasako M
Gastric Cancer; 2021 Mar; 24(2):492-502. PubMed ID: 33200303
[TBL] [Abstract][Full Text] [Related]
6. Short-term outcomes of gastrectomy after neoadjuvant chemotherapy for clinical stage III gastric cancer: propensity score-matched analysis of a multi-institutional database.
Umeda S; Kanda M; Nakanishi K; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Shimizu D; Kobayashi D; Tanaka C; Fujiwara M; Murotani K; Kodera Y
Surg Today; 2021 May; 51(5):821-828. PubMed ID: 33170366
[TBL] [Abstract][Full Text] [Related]
7. Observational Study Comparing Efficacy and Safety between Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy for Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer.
Yeh YS; Huang MY; Ma CJ; Huang CW; Tsai HL; Chen YC; Li CC; Yu FJ; Shih HY; Wang JY
J Oncol; 2020; 2020():6931317. PubMed ID: 32963531
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer.
Sah BK; Zhang B; Zhang H; Li J; Yuan F; Ma T; Shi M; Xu W; Zhu Z; Liu W; Yan C; Li C; Liu B; Yan M; Zhu Z
Nat Commun; 2020 Nov; 11(1):6093. PubMed ID: 33257672
[TBL] [Abstract][Full Text] [Related]
9. [Neoadjuvant and perioperative treatment of gastric cancer, current studies and new biomarkers].
Stocker G; Thieme R; Lordick F
Chirurg; 2021 Jun; 92(6):499-505. PubMed ID: 33566116
[TBL] [Abstract][Full Text] [Related]
10. Research status on immunotherapy trials of gastric cancer.
Liang C; Wu HM; Yu WM; Chen W
World J Clin Cases; 2021 Jul; 9(21):5782-5793. PubMed ID: 34368297
[TBL] [Abstract][Full Text] [Related]
11. History and emerging trends in chemotherapy for gastric cancer.
Yamashita K; Hosoda K; Niihara M; Hiki N
Ann Gastroenterol Surg; 2021 Jul; 5(4):446-456. PubMed ID: 34337293
[TBL] [Abstract][Full Text] [Related]
12. Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial.
Zhang X; Liang H; Li Z; Xue Y; Wang Y; Zhou Z; Yu J; Bu Z; Chen L; Du Y; Wang X; Wu A; Li G; Su X; Xiao G; Cui M; Wu D; Chen L; Wu X; Zhou Y; Zhang L; Dang C; He Y; Zhang Z; Sun Y; Li Y; Chen H; Bai Y; Qi C; Yu P; Zhu G; Suo J; Jia B; Li L; Huang C; Li F; Ye Y; Xu H; Wang X; Yuan Y; E JY; Ying X; Yao C; Shen L; Ji J;
Lancet Oncol; 2021 Aug; 22(8):1081-1092. PubMed ID: 34252374
[TBL] [Abstract][Full Text] [Related]
13. Essential updates 2019/2020: Perioperative and surgical management of gastric cancer.
Irino T; Matsuda S; Wada N; Kawakubo H; Kitagawa Y
Ann Gastroenterol Surg; 2021 Mar; 5(2):162-172. PubMed ID: 33860136
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of gastroscopic hemostasis in the treatment of acute gastric hemorrhage: A meta-analysis.
Pan HY; Wang XW; He QX; Lu YD; Zhang WY; Jin JW; Lin B
World J Gastrointest Oncol; 2023 Nov; 15(11):1988-1997. PubMed ID: 38077648
[TBL] [Abstract][Full Text] [Related]
15. Nab-paclitaxel plus S-1
Dai YH; Yu XJ; Xu HT; Zhuang L; Zhang MS; Zou YM; Fu Q; Qiu H; Yuan XL
Ther Adv Med Oncol; 2022; 14():17588359221118020. PubMed ID: 35983025
[TBL] [Abstract][Full Text] [Related]
16. DNA Methylation Biomarkers for Prediction of Response to Platinum-Based Chemotherapy: Where Do We Stand?
Tavares NT; Gumauskaitė S; Lobo J; Jerónimo C; Henrique R
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740584
[TBL] [Abstract][Full Text] [Related]
17. Association of dysbindin expression with individualized postoperative prognosis and chemotherapy benefit among patients with gastric adenocarcinoma.
Qian H; Lv X; Song Q; Su R; Xie T; Wu D; Chang R; Chen L; Yang Y; Chen Y; Wang X; Ru Y; Shang L; Guo X
J Cancer; 2021; 12(22):6740-6748. PubMed ID: 34659563
[No Abstract] [Full Text] [Related]
18. Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM).
Mazzei MA; Bagnacci G; Gentili F; Capitoni I; Mura G; Marrelli D; Petrioli R; Brunese L; Cappabianca S; Catarci M; Degiuli M; De Manzoni G; De Prizio M; Donini A; Romario UF; Funicelli L; Laghi A; Minetti G; Morgagni P; Petrella E; Pittiani F; Rausei S; Romanini L; Rosati R; Ianora AAS; Tiberio GAM; Volterrani L; Roviello F; Grassi R
Eur Radiol; 2022 Feb; 32(2):938-949. PubMed ID: 34383148
[TBL] [Abstract][Full Text] [Related]
19. Expression and mechanism of exosome-mediated A FOXM1 related long noncoding RNA in gastric cancer.
Zhang Y; Chen L; Ye X; Wu Z; Zhang Z; Sun B; Fu H; Fu C; Liang X; Jiang H
J Nanobiotechnology; 2021 May; 19(1):133. PubMed ID: 33971889
[TBL] [Abstract][Full Text] [Related]
20. Combinational dual drug delivery system to enhance the care and treatment of gastric cancer patients.
Xiao Y; Gao Y; Li F; Deng Z
Drug Deliv; 2020 Dec; 27(1):1491-1500. PubMed ID: 33100060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
